The science and politics of the new mRNA flu vaccine

Science Friday | Oct 10

A new mRNA flu vaccine made by Moderna was approved by the FDA in August, and is currently available for people aged 50 and over. The promise of an mRNA vaccine for flu is that it can be spun up more quickly than a traditional vaccine, meaning it could better match the flu strain that’s circulating.  

Is that what happened this year? How are the side effects? And how has dysfunction at the health agencies impacted rollout? Flora discusses these questions and more with vaccine researcher Anna Durbin.

Guest:

Dr. Anna Durbin is a vaccine researcher, professor of international health, and director of the Center for Immunization Research at the Johns Hopkins Bloomberg School of Public Health.

Transcripts for each episode are available within 1-3 days at sciencefriday.com.

Be alert for scams. WNYC never asks for nor accepts money for coverage or interviews. Anyone making such a request does not represent WNYC.

Top Stories

Darializa Avila-Chevalier on Mamdani, ICE and the NYPD

Who’s Running This Place |

Has MAGA Lost Faith in Donald Trump? Plus, Molly Fischer on Waymo

Rich Baris, a pollster supportive of MAGA, explains how the President lost control of his movement. And Fischer, a New Yorker staff writer, on the present and future of driverless cars.
The New Yorker Radio Hour |

Watch: Test your news knowledge with Brian Lehrer

Brian Lehrer leads special guests in a multi-round quiz of news oddities.
Radiolab |

A Nobel Peace Prize Winner on the State of Press Freedom and Democracy

The Brian Lehrer Show |
YOU ARE ONLINE